Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20160052884A1
公开(公告)日:2016-02-25
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
Enantioselective α-Functionalization of 1,3-Dithianes by Iridium-Catalyzed Allylic Substitution
作者:Panpan Wang、Qian Jiang、Ruibo Zhao、Xingang Xie、Shouchu Tang、Xiaolei Wang
DOI:10.1021/acs.joc.0c01683
日期:2020.10.2
iridium-catalyzed asymmetric allylicsubstitution reaction with 2-alkoxy carbonyl-1,3-dithianes has been achieved with high regio- and enantioselectivities. The transformation provides a new method for the enantioselective α-functionalization of dithianes. The corresponding dithiane-containing products are easily converted into many other derivatives with high yields and enantioselectivities.
ORALLY AVAILABLE VIRIDIOFUNGIN DERIVATIVE POSSESSING ANTI-HCV ACTIVITY
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US20150210666A1
公开(公告)日:2015-07-30
An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
Orally available viridiofungin derivative possessing anti-HCV activity
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US09266853B2
公开(公告)日:2016-02-23
An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US09434690B2
公开(公告)日:2016-09-06
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.